Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-02-01
|
| Series: | BMC Cancer |
| Online Access: | https://doi.org/10.1186/s12885-024-11932-4 |
| _version_ | 1797274298926235648 |
|---|---|
| author | Xiewei Huang Yushuai Yu Shiping Luo Wenfen Fu Jie Zhang Chuangui Song |
| author_facet | Xiewei Huang Yushuai Yu Shiping Luo Wenfen Fu Jie Zhang Chuangui Song |
| author_sort | Xiewei Huang |
| collection | DOAJ |
| first_indexed | 2024-03-07T14:56:24Z |
| format | Article |
| id | doaj.art-5b1c905167e5498cba81d906e015ca1f |
| institution | Directory Open Access Journal |
| issn | 1471-2407 |
| language | English |
| last_indexed | 2024-03-07T14:56:24Z |
| publishDate | 2024-02-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj.art-5b1c905167e5498cba81d906e015ca1f2024-03-05T19:23:02ZengBMCBMC Cancer1471-24072024-02-012411110.1186/s12885-024-11932-4Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysisXiewei Huang0Yushuai Yu1Shiping Luo2Wenfen Fu3Jie Zhang4Chuangui Song5Department of Breast Surgery, Fujian Medical University Union HospitalDepartment of Breast Surgery, Fujian Medical University Union HospitalDepartment of Breast Surgery, Fujian Medical University Union HospitalDepartment of Breast Surgery, Fujian Medical University Union HospitalDepartment of Breast Surgery, Fujian Medical University Union HospitalDepartment of Breast Surgery, Fujian Medical University Union Hospitalhttps://doi.org/10.1186/s12885-024-11932-4 |
| spellingShingle | Xiewei Huang Yushuai Yu Shiping Luo Wenfen Fu Jie Zhang Chuangui Song Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis BMC Cancer |
| title | Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis |
| title_full | Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis |
| title_fullStr | Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis |
| title_full_unstemmed | Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis |
| title_short | Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis |
| title_sort | correction the value of oral selective estrogen receptor degraders in patients with hr positive her2 negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy systematic review and meta analysis |
| url | https://doi.org/10.1186/s12885-024-11932-4 |
| work_keys_str_mv | AT xieweihuang correctionthevalueoforalselectiveestrogenreceptordegradersinpatientswithhrpositiveher2negativeadvancedbreastcancerafterprogressionon1lineofendocrinetherapysystematicreviewandmetaanalysis AT yushuaiyu correctionthevalueoforalselectiveestrogenreceptordegradersinpatientswithhrpositiveher2negativeadvancedbreastcancerafterprogressionon1lineofendocrinetherapysystematicreviewandmetaanalysis AT shipingluo correctionthevalueoforalselectiveestrogenreceptordegradersinpatientswithhrpositiveher2negativeadvancedbreastcancerafterprogressionon1lineofendocrinetherapysystematicreviewandmetaanalysis AT wenfenfu correctionthevalueoforalselectiveestrogenreceptordegradersinpatientswithhrpositiveher2negativeadvancedbreastcancerafterprogressionon1lineofendocrinetherapysystematicreviewandmetaanalysis AT jiezhang correctionthevalueoforalselectiveestrogenreceptordegradersinpatientswithhrpositiveher2negativeadvancedbreastcancerafterprogressionon1lineofendocrinetherapysystematicreviewandmetaanalysis AT chuanguisong correctionthevalueoforalselectiveestrogenreceptordegradersinpatientswithhrpositiveher2negativeadvancedbreastcancerafterprogressionon1lineofendocrinetherapysystematicreviewandmetaanalysis |